Catalina Teba, MD
- Clinical Assistant Professor, CWRU School of Medicine
- Specialty: Pulmonary and Critical Care Medicine, Pulmonary Disease
-
Location:UH Cleveland Medical Center Bolwell
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-8500
Biography: Catalina Teba, MD
Expertise
Certifications & Memberships
- Critical Care Medicine - American Board of Internal Medicine
- Pulmonary Disease - American Board of Internal Medicine
Education
Fellowship | Pulmonary/Critical Care
Pulmonary/Critical Care - Yale-New Haven Hospital (2009 - 2012)
Residency | Internal Medicine
Internal Medicine - Umdnj-Robert Wood Johnson University Hospital (2006 - 2009)
Medical Education
West Virginia University School Of Medicine (2006)
Undergraduate
West Virginia University (2001)
About
Catalina V. Teba, MD, is a pulmonologist at University Hospitals Cleveland Medical Center who specializes in the diagnosis and treatment of patients with cystic fibrosis and lung cancer. She is board-certified in both pulmonary disease and critical care medicine and is a clinical assistant professor at Case Western Reserve University School of Medicine.
Dr. Teba earned her medical degree from West Virginia School of Medicine in Morgantown, West Virginia. Her postdoctoral training began with an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, New Jersey. She then completed a pulmonary and critical care fellowship at Yale New Haven Hospital in Connecticut.
Dr. Teba has published multiple peer-reviewed journal articles and abstracts on pulmonary medicine, bronchoscopy navigations, lung cancer, critical care medicine and cystic fibrosis. She has also led several pulmonary related clinical trials.
Dr. Teba currently sits on several University Hospitals committees, including UH Lung Cancer Screening Committee Chair, UH Resuscitation Committee MICU Representative, UH Seidman Lung Cance Screening Physician Champion, and UH Seidman Cancer Center Lung Cancer Tumor Board.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Catalina Teba did not disclose any Outside Relationships with Industry.